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[This special issue of Translational Proteomics is focused on
Neuroproteomics” as a theme. Due to the complexity of the ner-
ous system, proteomics tools have been invaluable in terms of
iomarker and disease target discovery. Neuroproteomics encom-
asses the study of both the central nervous system and the
eripheral nervous system. It can be applied to normal neuro-
evelopment as well as normal aging process of the nervous
ystems such as aging of the brain. On the neuro-disorder side,
t covers neurological disorders such as stroke, epilepsy, neuro-
rauma, such as traumatic brain injury and spinal cord injury
r cerebral hemorrhage, neuro-psychiatric disorders such as
chizophrenia, depression, anxiety and substance abuse and lastly
eurodegenerative disorders such as Alzheimer’s disease, Parkin-
onism, ALS and other neuro-proteinopathy diseases. Another area
f special interest in neuro-biomarker discovery and/or validation.
In this special issue, we have three original and one topical
eview articles that employ proteomic methods and approaches
o tackle health and diseases of the nervous systems.
The ﬁrst article by Kamnaksha and colleagues addresses the
olecular changes that correlated to increased cerebral vulnera-
ility and functional deﬁcits after repeatedblast-induced traumatic
rain injury (TBI) They did so using a revere phase protein microar-
ay (RPPM) proteomic analyses of the selected brain regions in a
at model of blast overpressure wave-induced brain injury to show
vidence of signiﬁcant oxidative stress (HNE, HIF1-alpha) and vas-
ular changes (VEGF, AQP4, (vWF)), altered cell adhesion (Integrin
lpha 6, MMP8, TIMP1 & 4, Gal-1 and TLR9), and inﬂammation (p38
APK, OPN, MIP1-alpha, CCR5, OX44 and GFAP) in the prefrontal
ortex and other affected brain regions. Importantly, a number of
hese potential markers for blast TBI were also found to be elevated
n plasma samples from the injured rats. Thus this study has high
ranslational potentials [1,2].
The second article in this issue by Evans and colleagues uses a
ovel microwave and magnetic proteomic method to study pro-
eome changes in a mouse close-skull impact model for mild TBI.
he combined use of C8 magnetic beads and microwave-assisted
heating facilitate protein dissociation and thus improve sample
uality for subsequent tandem mass tagging isobaric labeling and
ass spectrometry-based protein identiﬁcation. The study results
ighlighted a few key biomarker candidates emerged from this
odel – including myelin basic protein (MBP), myelin associated
lycoprotein (MAG), alphaII-spectrin (SPNA2) and neuroﬁlament
rotein-light (NEFL). Importantly three out of four of these can-
[
ttp://dx.doi.org/10.1016/j.trprot.2014.09.001
212-9634/© 2014 The Authors. Published by Elsevier B.V. This is an open access article undidates have also been investigated in independent human brain
injury biomarker studies [3–6].
The third article of this series by García-Berrocoso and col-
leagues utilizes protein array approach to study chemokine
signatures after human ischemic stroke, with the aid of laser
microdissection from human ischemic brains as the source of
biosamples. Four chemokines are found to be altered – i.e. higher
levels of CCL1 and CCL2 in neurons than in vessels; decreased levels
of CCL5 and CCL22 in the infarcted areas. Again using ELISA array
performed in plasma samples from the same stroke patients, they
conﬁrmed that out of the four protein marker candidates, CCL22
showed signiﬁcant changes in plasma over time and that these
changes negatively correlated with neurological severity.
Lastly, Kobeissy et al. undated the readers with a topical review
article on using various neuroproteomic methods to study drug
abuseeffects on thebrain,withemphasis onpsychostimulants such
as cocaine, methamphetamine (METH) and 3,4-methylenedioxy-
N-methylamphetamine (MDMA) [7]. A total of 21 rodent-based
(mouse and rat) studies and a PC-12 cell culture based study were
reviewed. Methodology ranges from 2D-DIGE, iTRAQ-labeling to
shotgun proteomic analysis. These techniques tend to be comple-
mentary to each others in terms of identifying a comprehensive
proteome changes in the brain due to stimulant abuse.
Taken together the focus of the submitted articles is on either
preclinical animal studiesor clinical studiesbyapplyingproteomics
methods in traumatic and ischemic brain injury and substance
abuse. Several articles also addressed the translational components
relevant to clinical practice. We think you will enjoy this special
issue of TRRPOT on Neuroproteomics.
Happy Reading!
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